
|Articles|April 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach
- Volume 4
- Issue 4 Suppl
Point/Counterpoint: Is LDL-C Reduction the Outcome of Choice?
Advertisement
Articles in this issue
over 27 years ago
Participating Facultyover 27 years ago
Coronary Heart Disease in the United Statesover 27 years ago
Mechanisms of Acute Coronary Eventsover 27 years ago
Primary Preventionover 27 years ago
Pravastatin Event Reduction Analysisover 27 years ago
Secondary Preventionover 27 years ago
Methods and Mindsets in Pharmacoeconomicsover 27 years ago
Issues and Controversies in Pharmacoeconomicsover 27 years ago
Pharmacoeconomics Perspectives: Payers, Providers, and PatientsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
In Vivo CAR T Takes Center Stage, With Results Shared for 4 MRD-Negative Patients
2
Price Transparency With Gaps: Assessing the Completeness of Payer Transparency in Coverage Data
3
Camizestrant-Related Photopsia Mostly Mild, Nondisabling in Patients With Advanced Breast Cancer: Adam Brufsky, MD, PhD
4
T-DXd Delivers Strong Breast Cancer Outcomes Across Groups
5














































